OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
International Conference on Diabetes and Diabetic Nursing Care
September 28-29, 2018 Montreal, Canada
Type 1 diabetes usually develops as a result of autoimmune pancreatic beta-cell destruction in genetically susceptible individuals. Up to 90% of patients will have autoantibodies to at least one of 3 antigens: glutamic acid decarboxylase (GAD); insulin; and a tyrosine-phosphatase-like molecule, islet auto-antigen-2 (IA-2). [20] Beta-cell destruction proceeds sub-clinically for months to years as insulitis(inflammation of the beta cell).
There's no cure for diabetes, so treatment aims to keep your blood glucose levels as normal as possible and to control your symptoms to prevent health problems developing later in life. Treatment for type 1 diabetes includes: Taking insulin, Carbohydrate counting, Frequent blood sugar monitoring, Eating healthy foods ,Exercising regularly and maintaining a healthy weight blood sugar levels before meals between 70 and 130 mg/dL (3.9 to 7.2 mmol/L) and after meal Levels not higher than 180 mg/dL (10 mmol/L) two hours after eating should be maintained.
The European Commission Directorate General for Research and Innovation (DG RTD) and the JDRF (formerly Juvenile Diabetes Research Foundation) jointly organized a workshop held in Brussels on type 1 diabetes with the ultimate goal of defining the state-of-art in the field, identifying gaps, and brainstorming about the possibilities offered by personalized medicine approaches in this area. The speakers laid out that time frame for the next major advances in type 1 diabetes
